54 related articles for article (PubMed ID: 1313709)
1. [Coxsackie B4 and cytomegalovirus in patients with insulin-dependent diabetes].
Pato E; Cour MI; González Cuadrado S; González Gómez C; Muñoz JJ; Figueredo A
An Med Interna; 1992 Jan; 9(1):30-2. PubMed ID: 1313709
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
[TBL] [Abstract][Full Text] [Related]
3. Enterovirus infections with beta-cell tropic strains are frequent in siblings of children diagnosed with type 1 diabetes children and in association with elevated levels of GAD65 antibodies.
Frisk G; Tuvemo T
J Med Virol; 2004 Jul; 73(3):450-9. PubMed ID: 15170642
[TBL] [Abstract][Full Text] [Related]
4. Type 1 diabetes and Coxsackie virus infection.
Di Pietro C; Del Guercio MJ; Paolino GP; Barbi M; Ferrante P; Chiumello G
Helv Paediatr Acta; 1979; 34(6):557-61. PubMed ID: 232095
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile.
Schmidli RS; DeAizpurua HJ; Harrison LC; Colman PG
J Autoimmun; 1994 Feb; 7(1):55-66. PubMed ID: 8198702
[TBL] [Abstract][Full Text] [Related]
6. [Antibody levels against coxsackie B viruses in patients with type 1 diabetes mellitus].
Emekdaş G; Rota S; Kuştimur S; Kocabeyoğlu O
Mikrobiyol Bul; 1992 Apr; 26(2):116-20. PubMed ID: 1316989
[TBL] [Abstract][Full Text] [Related]
7. Analysis of antibody responses against coxsackie virus B4 protein 2C and the diabetes autoantigen GAD(65).
Vreugdenhil GR; Batstra MR; Aanstoot HJ; Melchers WJ; Galama JM
J Med Virol; 1999 Oct; 59(2):256-61. PubMed ID: 10459165
[TBL] [Abstract][Full Text] [Related]
8. Cold reacting antilymphocyte antibodies in type I (insulin dependent) diabetes.
Vialettes B; Mercier P; De Micco P; Lassmann V; Vague P
Diabete Metab; 1987 Feb; 13(1):12-5. PubMed ID: 3032702
[TBL] [Abstract][Full Text] [Related]
9. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
10. [Islet cell cytoplasmic antibodies (ICA) and complement-fixing islet cell cytoplasmic antibodies (CF-ICA) in patients with newly detected type 1 diabetes mellitus of short duration].
Majkowska L
Ann Acad Med Stetin; 1990; 36():95-111. PubMed ID: 2099111
[TBL] [Abstract][Full Text] [Related]
11. The relationship between Coxsackie-B-virus-specific IgG responses and genetic factors (HLA-DR, GM, KM) in insulin-dependent diabetes mellitus.
Field LL; McArthur RG; Shin SY; Yoon JW
Diabetes Res; 1987 Dec; 6(4):169-73. PubMed ID: 2834133
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study Group.
Ongagna JC; Levy-Marchal C
Diabetes Metab; 1997 Apr; 23(2):155-60. PubMed ID: 9137905
[TBL] [Abstract][Full Text] [Related]
13. Relationship between serum insulin autoantibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes.
Karjalainen J; Knip M; Hyöty H; Leinikki P; Ilonen J; Käär ML; Akerblom HK
Diabetologia; 1988 Mar; 31(3):146-52. PubMed ID: 3286341
[TBL] [Abstract][Full Text] [Related]
14. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
[TBL] [Abstract][Full Text] [Related]
15. [Cytoplasmic islet-cell antibodies (ICA) and cytoplasmic complement- fixing antibodies (CF-ICA) in patients with newly detected and short-lasting diabetes mellitus type 1].
Majkowska L; Czekalski S; Skwira J
Pol Tyg Lek; 1990 May 7-14; 45(19-20):384-8. PubMed ID: 2255656
[TBL] [Abstract][Full Text] [Related]
16. Association of type 2 diabetes mellitus and seroprevalence for cytomegalovirus.
Roberts BW; Cech I
South Med J; 2005 Jul; 98(7):686-92. PubMed ID: 16108236
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey].
Ataman S; Colak D; Günseren F; Senol Y; Colak T; Aktekin MR; Gültekin M
Mikrobiyol Bul; 2007 Oct; 41(4):545-55. PubMed ID: 18173073
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
Pietropaolo M; Yu S; Libman IM; Pietropaolo SL; Riley K; LaPorte RE; Drash AL; Mazumdar S; Trucco M; Becker DJ
Pediatr Diabetes; 2005 Dec; 6(4):184-92. PubMed ID: 16390386
[TBL] [Abstract][Full Text] [Related]
19. A longitudinal study of virus antibodies in patients with newly diagnosed type 1 (insulin-dependent) diabetes mellitus.
Buschard K; Madsbad S
J Clin Lab Immunol; 1984 Feb; 13(2):65-70. PubMed ID: 6327989
[TBL] [Abstract][Full Text] [Related]
20. Complement fixing antibodies against selected viruses in diabetic patients and non-diabetic control subjects in Ibadan, Nigeria.
Ajuwon ZA; Olaleye OD; Omilabu SA; Baba SS
Rev Roum Virol; 1992; 43(1-2):3-5. PubMed ID: 1288637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
